Tag: FTC

FTC

Regulatory/FDA

FTC Announces Final Rule to Prohibit Deceptive Online Reviews and Testimonials

FTC Announces Final Rule to Prohibit Deceptive Online Reviews and Testimonials

Effective on October 21st of this year, the Federal Trade Commission (FTC) issued a new final rule that is intended to better combat ​“fake” reviews and testimonials by prohibiting the sale or purchase of “fake reviews” as well as granting the agency the opportunity to seek civil penalties against ​willful violators. The FTC made only […]

Read more

Regulatory/FDA

FTC Revised Health Breach Notification Rule Goes into Effect

FTC Revised Health Breach Notification Rule Goes into Effect

Agencies with healthcare clients in pharmaceuticals, healthcare services, digital health apps, or health-related connected devices such as wearables should take note that the Federal Trade Commission (FTC) final rule updating its Health Breach Notification Rule (HBNR) that took effect on July 29, 2024. The FTC considers a breach to include a covered entity’s unauthorized disclosure […]

Read more

Regulatory/FDA

FTC Issues Final Version of Revised Health Breach Notification Rule

FTC Issues Final Version of Revised Health Breach Notification Rule

The Federal Trade Commission (FTC) issued a final rule on April 26, 2024 that updates its Health Breach Notification Rule (HBNR). The final rule definitions now encompass health apps and other technologies not covered by the Health Insurance Portability and Accountability Act (HIPAA). It also specifies what the FTC considers a breach of security, new […]

Read more

Regulatory/FDA

New Federal Overtime Rule to Impact Agencies

New Federal Overtime Rule to Impact Agencies

The U.S. Department of Labor (DOL) recent released a modified employee overtime pay rules. The new rules which take effect on July 1, 2024 (with a secondary deadline of January 1, 2025) will have a material impact on many U.S. businesses including marketing service companies. Background  The federal Fair Labor Standards Act (FLSA) guarantees minimum wages […]

Read more

Data Privacy

CHC & 4A’s Member-Exclusive HIPAA Guidance

CHC & 4A’s Member-Exclusive HIPAA Guidance

CHC & 4A’s Member-Exclusive Guidance Crafted jointly by the CHC and 4A’s, this first-of-its-kind industry guidance – Navigating the Health Data Privacy Landscape: A Guide for Agencies – is designed to help partner healthcare agencies and communications companies better understand health data privacy compliance given the new wave of laws and regulations cropping up around […]

Read more

Data Privacy

HHS-OCR & NIST Release Joint HIPAA Resource Guidance

HHS-OCR & NIST Release Joint HIPAA Resource Guidance

The HHS Office for Civil Rights (OCR) and the National Institute of Standards and Technology (NIST) published the final version of Special Publication (SP) 800-66 Revision 2, aimed at helping covered entities and business associates better understand and comply with the HIPAA Security Rule. The final version serves as a resource guide and maps the […]

Read more

Regulatory/FDA

Watch CHC On-Demand Webinar: The Future of FTC’s Privacy Regulations & Actions

Watch CHC On-Demand Webinar: The Future of FTC’s Privacy Regulations & Actions

  Watch our 30-minute webinar on-demand that cover the FTC’s jurisdiction in the health privacy space and HIPAA-adjacent ad agencies and communications companies, as well as how the FTC prioritizes enforcement actions in the health privacy space.  Gain insights on what the healthcare advertising industry can do better in terms of health privacy and what […]

Read more

Courts/First Amendment

CHC brief questions FTC ad market definition in IQVIA merger challenge

CHC brief questions FTC ad market definition in IQVIA merger challenge

WASHINGTON, DC – The Coalition for Healthcare Communication (CHC) has filed a federal court amicus brief that raises concerns about how the Federal Trade Commission (FTC) defined the “programmatic advertising” marketplace in its complaint against IQVIA’s proposed merger with Propel Media and offered its real-world insight into the industry, which span the entire digital “ad […]

Read more

Regulatory/FDA

FTC Releases New Staff Paper on Harms to Kids & Teens from Online “Blurred” or Stealth Advertising

FTC Releases New Staff Paper on Harms to Kids & Teens from Online “Blurred” or Stealth Advertising

The Federal Trade Commission (FTC) issued a new staff paper in conjunction with their open Commission meeting that recommends that advertisers, social media influencers, and others who market or promote products online to children should avoid blurring advertising by clearly separating advertising and entertainment, educational, and other content to help limit potential negative effects to […]

Read more